TheProfitWatch

LVTX - LAVA Therapeutics N.V. Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.53 -0.03 (-1.96%) --- --- --- 0.0 (0.0%) -0.01 (-0.33%) 0.0 (0.0%) 0.0 (0.0%)

LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.13
Diluted EPS:
-0.13
Basic P/E:
-11.5385
Diluted P/E:
-11.5385
RSI(14) 1m:
100.0
VWAP:
1.5
RVol:
0.6907

Events

Period Kind Movement Occurred At
1m Price increase 1m 1.52 +0.03 (+2.01%) Oct 15 15:58

Related News